Biography

Dr. Kebebew received his bachelor's degree from the University of California, Los Angeles, in chemical engineering. He completed his medical training, surgical residency and NCI T32 Surgical Oncology Basic Science fellowship at the University of California, San Francisco. Dr. Kebebew joined the surgical faculty at the University of California, San Francisco, in 2002. In 2009, Dr. Kebebew was recruited to be the Head of the Endocrine Oncology Section in the Surgery Branch. In 2012, he became Chief of the newly established Endocrine Oncology Branch. Dr. Kebebew has published over 300 articles, chapters and textbooks. He has received awards from the American Cancer Society, American Association for Cancer Research, American Thyroid Association, American Association of Endocrine Surgeons, and International Association of Endocrine Surgeons. His laboratory investigates the genetic/genomic changes associated with endocrine cancers with the ultimate goal of identifying therapeutic targets and novel anticancer agents for endocrine cancers, and diagnostic and prognostic markers for endocrine tumors. Dr. Kebebew is a Fellow of the American College of Surgeons, an internationally recognized expert in endocrine surgery, and has performed more than 3,000 operations on the adrenal, pancreas, parathyroid and thyroid. 

Research Intrest

Cancer Biology, Clinical Research, Genetics and Genomics 

List of Publications
Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, et al. (2016) Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 29: 723-736.
Satoh K, Zhang L, Zhang Y, Chelluri R, Boufraqech M, et al. (2016) Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical Carcinoma. Clin Cancer Res. 22/14: 3458-3466.
Sadowski SM, Neychev V, Millo C, Shih J, Nilubol N, et al. (2016) Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites. J. Clin Oncol. 34: 588-596.
Boufraqech M, Zhang L, Nilubol N, Sadowski SM, Kotian S, et al. (2016) Lysyl Oxidase (LOX) Transcriptionally Regulates SNAI2 Expression and TIMP4 Secretion in Human Cancers. Clin Cancer Res. 22: 4491-4504.